中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2015年
5期
947-949,955
,共4页
张源%金承龙%王申桐%杨洋%林贞花%金铁峰
張源%金承龍%王申桐%楊洋%林貞花%金鐵峰
장원%금승룡%왕신동%양양%림정화%금철봉
肺鳞癌%埃兹蛋白%免疫组织化学
肺鱗癌%埃玆蛋白%免疫組織化學
폐린암%애자단백%면역조직화학
Lung squamous carcinoma%Ezrin%Immunohistochemistry
目的:探讨第567位苏氨酸磷酸化的埃兹蛋白(pEZRThr567)在肺鳞癌、癌旁及正常肺组织中的表达及其临床病理学意义。方法:用免疫组化法检测pEZRThr567在肺癌、癌旁及正常肺组织中的表达,并分析其异常表达与临床病理学特点之间的相关性;用免疫荧光染色法检测pEZRThr567在肺鳞癌细胞EBC-1中的定位情况。结果:pEZRThr567蛋白在肺鳞癌组织中的表达明显高于癌旁组织和正常肺组织(P<0.01);pEZRThr567蛋白主要表达于细胞膜,且其表达与肿瘤分化程度、临床分期和有无淋巴结转移密切相关(P<0.05)。结论: pEZRThr567蛋白可作为肺鳞癌恶性进展的有效分子指标。
目的:探討第567位囌氨痠燐痠化的埃玆蛋白(pEZRThr567)在肺鱗癌、癌徬及正常肺組織中的錶達及其臨床病理學意義。方法:用免疫組化法檢測pEZRThr567在肺癌、癌徬及正常肺組織中的錶達,併分析其異常錶達與臨床病理學特點之間的相關性;用免疫熒光染色法檢測pEZRThr567在肺鱗癌細胞EBC-1中的定位情況。結果:pEZRThr567蛋白在肺鱗癌組織中的錶達明顯高于癌徬組織和正常肺組織(P<0.01);pEZRThr567蛋白主要錶達于細胞膜,且其錶達與腫瘤分化程度、臨床分期和有無淋巴結轉移密切相關(P<0.05)。結論: pEZRThr567蛋白可作為肺鱗癌噁性進展的有效分子指標。
목적:탐토제567위소안산린산화적애자단백(pEZRThr567)재폐린암、암방급정상폐조직중적표체급기림상병이학의의。방법:용면역조화법검측pEZRThr567재폐암、암방급정상폐조직중적표체,병분석기이상표체여림상병이학특점지간적상관성;용면역형광염색법검측pEZRThr567재폐린암세포EBC-1중적정위정황。결과:pEZRThr567단백재폐린암조직중적표체명현고우암방조직화정상폐조직(P<0.01);pEZRThr567단백주요표체우세포막,차기표체여종류분화정도、림상분기화유무림파결전이밀절상관(P<0.05)。결론: pEZRThr567단백가작위폐린암악성진전적유효분자지표。
AIM:To investigate the clinicopathological significance of the protein expression of phosphorylated ezrin at threonine 567 ( pEZRThr567 ) in lung squamous cell carcinoma, adjacent tissues and normal tissues.METHODS:pEZRThr567 protein was detected in lung squamous carcinoma, adjacent and normal tissues by the method of immunohisto-chemistry.The correlation of pEZRThr567 expression with clinicopathological parameters of lung squamous carcinomas was al-so analyzed.The localization of pEZRThr567 was detected by immunofluorescence staining in lung squamous cell line EBC-1. RESULTS:The protein expression of pEZRThr567 in lung squamous carcinoma was significantly higher than that in the adja-cent and normal lung tissues (P<0.01).pEZRThr567 mainly localized on the cell membrane, and its over-expression signi-ficantly correlated with the differentiation, clinical stage and lymph node metastasis in lung squamous carcinoma.CON-CLUSION:pEZRThr567 may be an effective biomarker for prediction of malignant potential and poor prognosis of lung cancer.